In Brief This Week: Affymetrix; LabCorp; Life Tech, DNAVEC, N-of-One; Qiagen; MDxHealth; Abbott: More | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix this week said it sold its Anatrace business to investment firm StoneCalibre for an undisclosed amount. Anatrace is based in Maumee, Ohio and is a highly specialized developer, manufacturer, and distributor of high-purity detergents and synthetic lipids used in membrane protein research. An Affymetrix spokesman said Anatrace's revenues were not material to the company's overall financials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.